{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:50:50Z","timestamp":1788630650583,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bioorg.2019.103162","type":"journal-article","created":{"date-parts":[[2019,7,28]],"date-time":"2019-07-28T01:07:06Z","timestamp":1564276026000},"page":"103162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Design, synthesis and antibacterial activity evaluation of moxifloxacin-amide-1,2,3-triazole-isatin hybrids"],"prefix":"10.1016","volume":"91","author":[{"given":"Feng","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.103162_b0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2017.09.050","article-title":"4-Quinolone hybrids and their antibacterial activities","volume":"141","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0010","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2018.03.016","volume":"150","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2019.04.043","article-title":"Antibacterial activity study of 1,2,4-triazole derivatives","volume":"173","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2019.04.033","article-title":"1,2,4-Triazole-quinoline\/quinolone hybrids as potential anti-bacterial agents","volume":"174","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0025","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejmech.2017.11.082","article-title":"4-Quinolone derivatives and their activities against Gram positive pathogens","volume":"144","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejmech.2018.11.032","article-title":"Fluoroquinolone-isatin hybrids and their biological activities","volume":"162","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejmech.2018.10.036","article-title":"Synthetic small molecules as anti-biofilm agents in the struggle against antibiotic resistance","volume":"161","author":"Parrino","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0040","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.ijantimicag.2019.03.020","article-title":"In-vitro studies on a natural lantibiotic, paenibacillin: a new-generation antibacterial drug candidate to overcome multi-drug resistance","volume":"53","author":"Jangra","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.bioorg.2019.103162_b0045","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ejmech.2018.08.061","article-title":"Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0050","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejmech.2018.08.095","article-title":"Recent developments of quinolone-based derivatives and their activities against Escherichia coli","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.coph.2014.09.007","article-title":"Novel compounds targeting bacterial DNA topoisomerase\/DNA gyrase","volume":"18","author":"Ehmann","year":"2014","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bioorg.2019.103162_b0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","article-title":"Fourth generation fluoroquinolones: New weapons in the arsenal of ophthalmic antibiotics","volume":"133","author":"Mather","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.bioorg.2019.103162_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102965","article-title":"Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents","volume":"88","author":"Ture","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.annepidem.2013.12.009","article-title":"Peripheral neuropathy and Guillain-Barr\u00e9 syndrome risks associated with exposure to systemic fluoroquinolones: a pharmacovigilance analysis","volume":"24","author":"Ali","year":"2014","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.bioorg.2019.103162_b0075","first-page":"s211","article-title":"Acute fulminant hepatic failure and toxic epidermal necrolysis associated with the use of moxifloxacin","volume":"98","author":"Deenadayalu","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bioorg.2019.103162_b0080","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jcrs.2017.03.043","article-title":"Topical moxifloxacin-induced Stevens-Johnson syndrome","volume":"43","author":"Das","year":"2017","journal-title":"J. Cataract. Refract. Surg."},{"key":"10.1016\/j.bioorg.2019.103162_b0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jphotobiol.2004.11.014","article-title":"Evaluation of phototoxic and photoallergic potentials of 13 compounds by different in vitro and in vivo methods","volume":"79","author":"Neumann","year":"2005","journal-title":"J. Photochem. Photobiol. B"},{"key":"10.1016\/j.bioorg.2019.103162_b0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejmech.2019.01.033","article-title":"Molecular diversity of trimethoxyphenyl-1,2,3-triazole hybrids as novel colchicine site tubulin polymerization inhibitors","volume":"165","author":"Fu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2019.01.017","article-title":"Quinolone hybrids and their anticancer activities: an overview","volume":"165","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cclet.2016.07.032","article-title":"Isatin hybrids and their anti-tuberculosis activity","volume":"28","author":"Xu","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103162_b0105","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejmech.2017.06.051","article-title":"Triazole derivatives and their anti-tubercular activity","volume":"138","author":"Zhang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0110","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","article-title":"The 1,2,3-triazole ring as a bioisostere in medicinal chemistry","volume":"22","author":"Bonandi","year":"2017","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2019.103162_b0115","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1016\/j.bmcl.2009.06.030","article-title":"Respiratory syncytial virus fusion inhibitors. Part 7: Structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo","volume":"19","author":"Sin","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103162_b0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejmech.2019.02.055","article-title":"Comprehensive review on the anti-bacterial activity of 1,2,3-triazole hybrids","volume":"168","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0125","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmech.2018.12.017","article-title":"Isatin derivatives and their anti-bacterial activities","volume":"164","author":"Guo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0130","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejmech.2018.12.001","article-title":"Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents","volume":"163","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejmech.2017.05.057","article-title":"Azide-alkyne cycloaddition towards 1H\u20131,2,3-triazole-tethered gatifloxacin and isatin conjugates: design, synthesis and in vitro anti-mycobacterial evaluation","volume":"138","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0140","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1016\/j.bmcl.2017.07.023","article-title":"Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids","volume":"27","author":"Xu","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103162_b0145","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ejmech.2018.07.025","article-title":"Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids","volume":"156","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0150","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1002\/jhet.2933","article-title":"Design, synthesis and in vitro anti-mycobacterial evaluation 1H\u20131,2,3-triazole-tethered ciprofloxacin and isatin conjugates","volume":"54","author":"Hu","year":"2017","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0155","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1002\/jhet.2980","article-title":"1H\u20131,2,3-triazole-tethered 8-OMe ciprofloxacin and isatin hybrids: design, synthesis and in vitro anti-mycobacterial activities","volume":"54","author":"Xu","year":"2017","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jhet.3004","article-title":"Design, synthesis and in vitro anti-mycobacterial activities of 8-OMe ciprofloxacin-1H-1,2,3-triazole-isatin-(thio) semicarbazide\/oxime hybrids","volume":"55","author":"Xu","year":"2018","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0165","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jhet.3382","article-title":"Ciprofloxacin-isatin hybrids and their antimycobacterial activities","volume":"56","author":"Xu","year":"2019","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0170","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ejmech.2017.11.090","article-title":"Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities","volume":"143","author":"Yan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0175","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejmech.2018.01.078","article-title":"Ciprofloxacin derivatives and their antibacterial activities","volume":"146","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0180","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1016\/j.bmcl.2012.05.026","article-title":"Studies on the antimicrobial properties of N-acylated ciprofloxacins","volume":"22","author":"Cormier","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103162_b0185","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1021\/acsmedchemlett.5b00146","article-title":"Syntheses and antibacterial activity of N-acylated ciprofloxacin derivatives based on the trimethyl lock","volume":"6","author":"Ji","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103162_b0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/cbdv.201400456","article-title":"Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of \u03b2-Octaarginine","volume":"12","author":"Purkayastha","year":"2015","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2019.103162_b0195","doi-asserted-by":"crossref","first-page":"9244","DOI":"10.1021\/ja402326z","article-title":"Bifunctional unnatural sialic acids for dual metabolic labeling of cell-surface sialylated glycans","volume":"135","author":"Feng","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2019.103162_b0200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmech.2018.09.049","article-title":"Design, synthesis and anti-mycobacterial activity evaluation of benzofuran-isatin hybrids","volume":"159","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.103162_b0205","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1016\/j.bmcl.2005.08.068","article-title":"In silico fragment-based discovery of indolin-2-one analogues as potent DNA gyrase inhibitors","volume":"15","author":"Oblak","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.103162_b0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.molstruc.2016.03.036","article-title":"Design, synthesis and antibacterial activity of isatin derivatives as FtsZ inhibitors","volume":"1117","author":"Lian","year":"2016","journal-title":"J. Mol. Struct."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819309654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206819309654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:54:33Z","timestamp":1758614073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206819309654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":42,"alternative-id":["S0045206819309654"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103162","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and antibacterial activity evaluation of moxifloxacin-amide-1,2,3-triazole-isatin hybrids","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.103162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103162"}}